MYLAN ApS: Financial statements 2020
CVR: 28107013
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MYLAN ApS (CVR 28107013) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,178 and a net result of DKK 2,079 compared with DKK 1,952 the year before. That is an increase of 10.7% compared with the year before. Equity in the 2020 report amounted to DKK 191,754. The solvency ratio was 54.8%.
- Gross Profit
- DKK 5,178
- Profit/Loss
- DKK 2,079
- Equity
- DKK 191,754
- Total Assets
- DKK 349,701
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5 t. | 2 t. | 192 t. | 0 |
| 2019 | - | 5 t. | 2 t. | 190 t. | 0 |
| 2018 | - | 3 t. | 1 t. | 188 t. | 0 |
| 2017 | - | 2 t. | 2 t. | 186 t. | 0 |
| 2016 | - | 3 t. | 2 t. | 185 t. | - |
How creditworthy is MYLAN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
MYLAN ApS has published its annual report for 2019. Gross profit came to DKK 4,677, and the net result was DKK 1,952.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.